ALZN Return on Tangible Equity | ALZAMEND NEURO, INC.

ALZAMEND NEURO, INC. (ALZN) Return on Tangible Equity

2026-04-30: Return Tang Equity -1196.43%.
2026-01-31: Return Tang Equity -320.09%.
2025-10-31: Return Tang Equity -134.48%.
2025-07-31: Return Tang Equity -116.84%.

Complete source-backed return tang equity history.

Available history: 2020-04-30 to 2026-04-30
Data captured: 2026-09-04

Historical Return Tang Equity

Date	Return Tang Equity
2026-04-30	-1196.43%
2026-01-31	-320.09%
2025-10-31	-134.48%
2025-07-31	-116.84%
2025-04-30	-113.78%
2025-01-31	-122.53%
2024-10-31	-155.87%
2024-07-31	609.94%
2024-04-30	383.46%
2024-01-31	290.86%
2023-10-31	565.33%
2023-07-31	13614.86%
2023-04-30	-488.53%
2023-01-31	-263.54%
2022-10-31	-143.27%
2022-07-31	-116.97%
2022-04-30	-92.59%
2022-01-31	-81.50%
2021-10-31	-63.69%
2021-07-31	-39.43%
2021-04-30	-250.71%

Annual Return Tang Equity

Date	Return Tang Equity
2026-04-30	-1196.43%
2025-04-30	-113.78%
2024-04-30	383.46%
2023-04-30	-488.53%
2022-04-30	-92.59%
2021-04-30	-250.71%
2020-04-30	-536.72%

Similar stocks

Stock Name	Country	Market Cap	PE Ratio
Traws Pharma, Inc. (TRAW)	United States	$0.009B	-0.58
FibroBiologics, Inc. (FBLG)	United States	$0.009B	-0.27
Imunon, Inc. (IMNN)	United States	$0.008B	-0.56
SOLIGENIX, INC. (SNGX)	United States	$0.008B
EXICURE, INC. (XCUR)	United States	$0.008B	-1.54
Ensysce Biosciences, Inc. (ENSC)	United States	$0.008B	-0.37
Aprea Therapeutics, Inc. (APRE)	United States	$0.010B	-0.78
InMed Pharmaceuticals Inc. (INM)		$0.008B	-0.65
Apimeds Pharmaceuticals US, Inc. (APUS)	United States	$0.008B
Medicus Pharma Ltd. (MDCX)		$0.010B